AnnexMedAnnexMedAnnexMed
Corporate Office
USA
299 S. Main Street
Suite 1300
Salt Lake City, UT 84111
Chennai - Tower I
CeeDeeYes Tyche Towers,
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
Chennai - Tower II
4th Floor, IIFL TOWERS
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram
No 9, Viswalingam Layout
Villupuram,
Tamil Nadu – 605602

Hospital outpatient & 340b pharmacy

Revenue Cycle & 340B Integrity for
Hospital Pharmacy Operations

Hospital outpatient pharmacies sit at the intersection of medical billing, retail dispensing, and 340B program economics. AnnexMed delivers integrated RCM and 340B program support as a single capability — built for the hospital CFO, the pharmacy director, and the 340B compliance officer working from the same numbers.

AUDIT-READY

340B documentation

15–25%

Revenue improvement

ALL 50

States coverage

Explore Hospital pharmacy solutions

Outpatient Pharmacy RCM

End-to-end revenue cycle for hospital outpatient, discharge, and ambulatory care pharmacy — eligibility, prior auth, billing, denial management, and patient collections.

340B Program Support & Audit Readiness

Eligibility determination per encounter, mixed-use reconciliation, contract pharmacy TPA management, duplicate discount detection, and HRSA audit preparation.

The hospital pharmacy revenue cycle reality

The Challenges Keeping Pharmacy Directors & 340B Officers Awake

340B Program at Risk

Manufacturer policy changes on contract pharmacy, HRSA audit findings, and rising scrutiny on duplicate discounts can erode 340B savings overnight. For a mid-size hospital, $3M–$15M in annual savings hangs on documentation quality.

Mixed-Use Complexity

The same drug billed differently depending on patient encounter type, 340B eligibility, and payer rules. Inpatient-to-outpatient transitions, infusion administered in outpatient settings, and same-day surgery pharmaceuticals each follow different rules.

Manufacturer Restrictions

Over 30 pharmaceutical manufacturers now restrict contract pharmacy participation. Each restriction has different rules, dispute mechanisms, and reporting requirements that demand active management — not quarterly review

TPA Reconciliation Lag

Third-party administrator data typically lags real-time dispensing by 30–90 days. Without continuous reconciliation, missed eligibility, duplicate discounts, and chargeback errors accumulate before they are caught.

Outpatient Pharmacy Economics

Razor-thin margins on retail dispensing make billing accuracy a survival issue. A 2% reimbursement error compounded over thousands of fills is the difference between profitable and shut-down.

HRSA Audit Exposure

HRSA audits target documentation completeness across encounter eligibility, mixed-use ratios, prescription origination, and provider relationships. Unprepared hospitals face recoupment, integrity findings, and program loss.

Who we are for hospital pharmacies

We Become Your Hospital Pharmacy Revenue & Compliance Partner

AnnexMed delivers revenue cycle operations and 340B program support as a single integrated capability — the same team understands hospital outpatient billing, contract pharmacy reconciliation, mixed-use accounting, and HRSA audit readiness. We don’t hand off between billing vendors and 340B consultants. One team, one accountability.
We serve hospital outpatient pharmacies, ambulatory care pharmacies, hospital-owned specialty pharmacies, contract pharmacy networks, and the 340B compliance offices that depend on them. Already supporting hospital CFOs across all 50 states with multi-facility delivery, consolidated reporting, and audit-ready documentation.

Recent Client Results

A 340-bed regional health system recovered $2.4M in unreported 340B savings within 90 days of go-live by reconciling 14 months of TPA discrepancies. A 220-bed community hospital reduced outpatient pharmacy denial rate from 19% to 6% within six months while passing its first HRSA audit with zero findings. A 4-facility hospital system consolidated 340B reconciliation across all sites and identified $1.8M in duplicate discount exposure that had not been caught by their prior vendor.

Zero

HRSA Audit Findings Across Client Base

48–72 hrs

Mixed-Use Reconciliation Turnaround

$2M–$8M+

Typical Annual Financial
Impact

How annexmed supports your hospital pharmacy

Full Revenue Cycle Plus 340B Program Integrity

By integrating outpatient pharmacy RCM with 340B program support under one operations team, we close the gaps where revenue and savings get lost — eligibility errors, mixed-use mis-routing, missed chargebacks, and audit documentation drift. One platform, one workflow, one source of truth.

Outpatient RCM

Pharmacy revenue cycle

340B Program Support

Savings and compliance

Analytics & Integrity

Revenue and savings visibility

Financial impact and performance

What these improvements mean in Dollars?

For a 200–400 bed hospital with active 340B program and outpatient pharmacy operations, AnnexMed’s combined impact regularly delivers $2M–$8M+ in net annual financial benefit — split between recovered revenue, protected 340B savings, and prevented audit recoupment. Most hospitals achieve full ROI within 6–9 months.

Audit-Ready From Day One

Every 340B transaction is documented, reconciled, and archived against current HRSA guidance — so audits become routine reviews, not emergencies. No more pulling documentation under pressure.

Built for Hospital Workflows

We integrate with Epic Willow, Cerner Retail, McKesson EnterpriseRx, and major 340B TPAs including Apexus, SUNRx, Verity Solutions, and Sentry Data Systems. Implementation typically completed in 3–4 weeks.
Improvement Area
Estimated Annual Impact
Unreported 340B Savings Recovery

$1M – $3M+ in one-time recovery during first 90 days

Mixed-Use Reconciliation Recovery

$500K – $1.5M annually in correctly routed claims

Duplicate Discount Detection

$300K – $1M annually in prevented recoupment exposure

Outpatient Pharmacy Denial Reduction (19% → 6%)

$800K – $2.5M annually in recovered revenue

A/R Days Reduction (65 → 45 days)

$1.5M – $4M in freed working capital

HRSA Audit Defense Value

$500K – $5M+ in protected savings and prevented penalties

Contract Pharmacy Network Optimization

$200K – $800K annually in chargeback recovery

Hospital Pharmacy Performance Targets

KPIs we hold ourselves accountable to — tracked in real time through your executive dashboards:
Performance Metric
Industry Benchmark
AnnexMed Target
340B Eligibility Determination Accuracy

Industry avg: 92–96%

99%+
Clean Claims Rate

Industry avg: 84–88%

> 95% first-pass
Outpatient Pharmacy Denial Rate

Hospital outpatient avg: 15–22%

< 6%
Days in A/R

Industry avg: 60–80 days

< 45 days
Mixed-Use Reconciliation Lag

Industry avg: 30–90 days

< 72 hours
HRSA Audit Findings

National hospital avg: 1.6 findings per audit

Zero
TPA Discrepancy Resolution

Industry avg: 30+ days

< 7 days
Contract Pharmacy Reconciliation

Industry standard: Quarterly

Continuous

Why hospitals choose annexmed for pharmacy?

In-House Operations vs. AnnexMed Partnership

The comparison at hospital scale isn’t only about cost — it’s about whether 340B savings and outpatient revenue actually reach the bottom line, and whether the audit infrastructure exists to defend them:
In-House / Traditional
AnnexMed Partnership
340B Eligibility

Manual rules applied inconsistently across departments; documentation
drift over time

Encounter-level eligibility determination with full audit trail and source documentation

TPA Reconciliation

Quarterly catch-up; revenue and savings often lost before discovery

Continuous reconciliation with daily discrepancy alerts and root-cause routing

Duplicate Discounts

Detected reactively during HRSA audit or manufacturer dispute

Detected pre-claim through automated NDC and encounter checks

Outpatient AR

Mixed in with hospital AR; deprioritized vs. inpatient large-dollar accounts

Dedicated outpatient pharmacy AR team and segment-specific reporting

HRSA Audit Response

Months of documentation pulled under pressure; risk of incomplete records

Pre-organized audit packages by NDC, encounter, provider, and date

Manufacturer Restrictions

Tracked manually; missed restrictions trigger chargebacks

Active restriction tracking with dispute and resubmission workflow

Mixed-Use Accounting

Spreadsheet-based, reconciled quarterly

Real-time mixed-use ratio dashboards by facility and provider

Multi-Facility Standardization

Each facility runs its own 340B process; reporting fragmented

Unified processes across facilities, consolidated reporting, 30–45 day acquisition integration

Real cost example: 250-bed community hospital with active 340B program

In-House: $620,000 annual cost (1.5 FTE 340B coordinator + 4 FTE outpatient pharmacy billing + software licensing) + estimated $1.2M annual exposure (unreported savings, duplicate discounts, audit risk). AnnexMed: $410,000 annual partnership fee + projected $2.4M annual financial benefit (recovered savings, reduced denials, A/R acceleration, audit protection) = net annual financial benefit of approximately +$2.0M per year, plus reduced HRSA exposure.

Technology

Powered by proprietary AI & analytics

AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.

AI Agents & Automation

AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.

Data & Analytics Platform

Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.

Intelligent AR Management

Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.

Computer Assisted Coding

Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.

Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.

Hospital pharmacy settings we serve

Built for the Full Range of Hospital Pharmacy Operations

AnnexMed supports every major hospital pharmacy setting and 340B configuration — each with delivery calibrated to its reimbursement model, regulatory environment, and program type:

Hospital Outpatient Pharmacy

Discharge pharmacy, ambulatory care pharmacy, employee health pharmacy — billed under hospital outpatient and retail rules, with 340B reconciliation where applicable.

Contract Pharmacy Networks

Hospital 340B contract pharmacy arrangements with external retail pharmacies — TPA reconciliation, virtual inventory, and chargeback recovery across the full network.

Hospital-Owned Specialty Pharmacy

Hospital-operated specialty pharmacy with integrated medical and pharmacy benefit billing, hub coordination, and 340B chargeback management.

Critical Access Hospital & FQHC Pharmacy

Smaller-scale hospital pharmacy operations with 340B program eligibility — full-service RCM scaled to facility size and resources.

Infusion & Injection Clinics

Hospital-based and hospital-owned ambulatory infusion centers with buy-and-bill economics, J-code billing, and site-of-service differential
management.

Disproportionate Share Hospital (DSH)

Large-volume DSH-eligible hospitals with high 340B savings exposure — multi-facility consolidation, audit defense, and savings integrity reporting

user-bg

Ready to Protect Your 340B Program & Recover Outpatient Pharmacy Revenue?

Most hospitals identify $1.5M–$4M in recoverable savings and revenue in their first assessment. Schedule a no-obligation Hospital Pharmacy Assessment and see where your revenue cycle and 340B program stand.

Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant

man-annex-CTA

Payer client outcomes

AnnexMed delivers measurable financial impact within the first 60 to 90 days of engagement. The following represent outcomes from active payer partnerships:

$15M–$40M

Risk
Adjustment

$18M–$50M

Payment
Integrity

6 Weeks

Credentialing Clearance

$15M–$50M+

Revenue
Impact

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.
Claims adjudication backlogs were delaying provider payments and increasing complaint volumes. AnnexMed took over processing, cleared the backlog in 30 days, and improved turnaround by 45%. Provider satisfaction scores climbed significantly, dispute volumes dropped, and our network relationships strengthened significantly.
Anx Image

Dr. Richard Calloway

Horizon Health Plan
Our payer operations team was overwhelmed with member inquiries, provider disputes, and claims rework. AnnexMed brought dedicated support that handled every function with accuracy and speed. Processing errors dropped by 60%, provider abrasion decreased, and our operational costs came down by nearly a third.
Anx Testimonial

Dr. Priya Menon

Crestview Insurance Partners
Managing claims accuracy, provider data, and member support internally was draining our resources. AnnexMed streamlined our payer operations end to end. Claims processing improved, provider onboarding accelerated, and our administrative burden reduced dramatically. They understand payer complexity like no other partner.
Anx Testimonial

Laura Simmons

Meridian Managed Care

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Certification

Want to talk to our RCM experts?

    Annexmed-logo
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.